Frontiers in Cardiovascular Medicine

Article	Citations
Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study	107
Arterial Stiffness and Hypertension in the Elderly	97
Hydrophilic or Lipophilic Statins?	94
Vascular Tissue Engineering: Polymers and Methodologies for Small Caliber Vascular Grafts	90
Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms	86
The Evolving Understanding and Approach to Residual Cardiovascular Risk Management	82
Predicting Diagnostic Gene Biomarkers Associated With Immune Infiltration in Patients With Acute Myocardial Infarction	79
Natural Biomaterials for Cardiac Tissue Engineering: A Highly Biocompatible Solution	79
COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus	78
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae	75
Improving the Generalizability of Convolutional Neural Network-Based Segmentation on CMR Images	74
Endothelial-to-Mesenchymal Transition, Vascular Inflammation, and Atherosclerosis	73
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition	72
The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population	70
Application of Machine Learning in Diagnosis of COVID-19 Through X-Ray and CT Images: A Scoping Review	69
The Role of the VEGF Family in Coronary Heart Disease	66
Association Between Periodontal Disease and Atherosclerotic Cardiovascular Diseases: Revisited	66
Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players	66
Advances in IVUS/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging	66
Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms	64
Vascular Manifestations of COVID-19 – Thromboembolism and Microvascular Dysfunction	62
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO)	61
Covid-19 Kills More Men Than Women: An Overview of Possible Reasons	60
Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis	60
Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis	59

Association Between Triglyceride-Glucose Index and Hypertension: A Meta-Analysis	59
SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity	58
Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview	56
Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock	55
Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using 68Ga-FAPI PET/CT	54
Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis	54
A Bibliometric Analysis of Exosomes in Cardiovascular Diseases From 2001 to 2021	54
Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases	53
COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies	53
A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease	52
Endothelial Cells in Emerging Viral Infections	51
Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases	50
CD4+ T-lymphocytes exhibit biphasic kinetics post-myocardial infarction	50
The Link Between Ferroptosis and Cardiovascular Diseases: A Novel Target for Treatment	49
Recent Development in Therapeutic Cardiac Patches	49
Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol	49
Procedure-Related Complications of Left Bundle Branch Pacing: A Single-Center Experience	49
First in-human quantitative plaque characterization with ultra-high resolution coronary photon-counting CT angiography	48
circSnx12 Is Involved in Ferroptosis During Heart Failure by Targeting miR-224-5p	48
Lipid Profile Features and Their Associations With Disease Severity and Mortality in Patients With COVID-19	48
The Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort Studies	47
Long COVID-19 and Postural Orthostatic Tachycardia Syndrome- Is Dysautonomia to Be Blamed?	45
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study	44
miR-21 in Human Cardiomyopathies	43
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy	43
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis	43
Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies	43
Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs	42
Inflammation in Metabolic Cardiomyopathy	42
Hemodynamic Relevance of Anomalous Coronary Arteries Originating From the Opposite Sinus of Valsalva-In Search of the Evidence	42
Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines	42
Use of Multi-Modal Data and Machine Learning to Improve Cardiovascular Disease Care	41
Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients	41
Association of Systemic Immune-Inflammation Index With Short-Term Mortality of Congestive Heart Failure: A Retrospective Cohort Study	41
The Predictive Value of Right Ventricular Longitudinal Strain in Pulmonary Hypertension, Heart Failure, and Valvular Diseases	41
Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles	41
Protective Effects of Dexazoxane on Rat Ferroptosis in Doxorubicin-Induced Cardiomyopathy Through Regulating HMGB1	40
Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve	40
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System	40
Telemedicine in Heart Failure During COVID-19: A Step Into the Future	39
Optimizing Outcomes in Cardiac Rehabilitation: The Importance of Exercise Intensity	39
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials	38
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection	38
Diagnostic and Prognostic Biomarkers for Myocardial Infarction	38
Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications	38
Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel	36
Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence	36
Gut Microbiota and Atherosclerosis—Focusing on the Plaque Stability	36
Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRA	36
PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation	36

Incidence of Venous Thromboembolism in Hospitalized Coronavirus Disease 2019 Patients: A Systematic Review and Meta-Analysis	36
Systemic Mesenchymal Stem Cell-Derived Exosomes Reduce Myocardial Infarct Size: Characterization With MRI in a Porcine Model	36
Triglyceride Glucose Index Is Associated With Arterial Stiffness and 10-Year Cardiovascular Disease Risk in a Chinese Population	35
Sex and gender differences in myocarditis and dilated cardiomyopathy: An update	35
Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis	35
Acute Myocardial Infarction During the COVID-19 Pandemic: An Update on Clinical Characteristics and Outcomes	35
Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy	35
Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors	35
The Role of Interleukin-6 Family Members in Cardiovascular Diseases	35
Impact of Metabolic Syndrome and It's Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis	35
Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection—A Cross-Sectional Study	35
Cardiomyocytes Cellular Phenotypes After Myocardial Infarction	34
Hypertension and COVID-19: Ongoing Controversies	34
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy	34
Endocan: A Key Player of Cardiovascular Disease	34
Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID	34
Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction	34
Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus	34
The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation	34
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review	34
Robotic Cardiac Surgery in Europe: Status 2020	33
Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target	33
Antidepressant Drugs Effects on Blood Pressure	33
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review	33
Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients	33
COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy	32
Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation	32
A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials	32
Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis	32
Radiomics Signatures of Cardiovascular Risk Factors in Cardiac MRI: Results From the UK Biobank	32
Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol	32
Role of MicroRNAs in the Pathogenesis of Coronary Artery Disease	31
Evidence for the Benefits of Melatonin in Cardiovascular Disease	31
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis	31
Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease	31
Gender-Related Differences in Heart Failure Biomarkers	31
Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer	31
Prevalence of Atrial Fibrillation and Associated Mortality Among Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis	31
Fairness in Cardiac Magnetic Resonance Imaging: Assessing Sex and Racial Bias in Deep Learning-Based Segmentation	31
Aortic Stiffness: Epidemiology, Risk Factors, and Relevant Biomarkers	30
The Role of Artificial Intelligence in Cardiovascular Imaging: State of the Art Review	30
Artificial intelligence in cardiology: Hope for the future and power for the present	30
Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?	30
Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective	30
Iron in Cardiovascular Disease: Challenges and Potentials	30
The Link Between Sex Hormones and Susceptibility to Cardiac Arrhythmias: From Molecular Basis to Clinical Implications	29
Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies	29
Cardiac Rehabilitation: A Bibliometric Review From 2001 to 2020	29
Atherogenic Index of Plasma and Coronary Artery Disease in the Adult Population: A Meta-Analysis	29
Machine Learning Approaches for Predicting Hypertension and Its Associated Factors Using Population-Level Data From Three South Asian Countries	29
The Associations of Lipid Profiles With Cardiovascular Diseases and Death in a 10-Year Prospective Cohort Study	29
Myocardial Disease and Long-Distance Space Travel: Solving the Radiation Problem	29
The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype	29
SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock	29
Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases	29
Gender Differences in Atherosclerotic Vascular Disease: From Lipids to Clinical Outcomes	29
Mechanisms of Atherosclerosis Induced by Postprandial Lipemia	29
Rheumatic Heart Valve Disease Pathophysiology and Underlying Mechanisms	29
Electrocardiogram-Based Heart Age Estimation by a Deep Learning Model Provides More Information on the Incidence of Cardiovascular Disorders	29
Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovas	29
Deep Learning for Detecting and Locating Myocardial Infarction by Electrocardiogram: A Literature Review	28
Endothelial to Mesenchymal Transition: An Insight in Atherosclerosis	28
Carotid Intima-Media Thickness in Healthy Children and Adolescents: Normative Data and Systematic Literature Review	28
Iron Deficiency: A New Target for Patients With Heart Failure	28
Wall shear stress and its role in atherosclerosis	28
In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study	28
Myofibroblast-Derived Exosome Induce Cardiac Endothelial Cell Dysfunction	28
Left Bundle Branch Pacing: Current Knowledge and Future Prospects	28
Longevity Factor FOXO3: A Key Regulator in Aging-Related Vascular Diseases	28
Wnt Signaling in Vascular Calcification	28
Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities	28
Association Between Stress Hyperglycemia Ratio and In-hospital Outcomes in Elderly Patients With Acute Myocardial Infarction	28
Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study	28
miR-135b-3p Promotes Cardiomyocyte Ferroptosis by Targeting GPX4 and Aggravates Myocardial Ischemia/Reperfusion Injury	28
Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity	27
Machine Learning for Clinical Decision-Making: Challenges and Opportunities in Cardiovascular Imaging	27
Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics	27
Risk Factors for Anthracycline-Induced Cardiotoxicity	27
The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases	27
NLRP3 inflammasome: The rising star in cardiovascular diseases	27

Momordica. charantia-Derived Extracellular Vesicles-Like Nanovesicles Protect Cardiomyocytes Against Radiation Injury via Attenuating DNA Damage and Mitochondria Dysfunction	27
Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease	27
The Effects of Fish Oil on Cardiovascular Diseases: Systematical Evaluation and Recent Advance	27
The Interplay Between Adipose Tissue and Vasculature: Role of Oxidative Stress in Obesity	27
A Guide to Left Bundle Branch Area Pacing Using Stylet-Driven Pacing Leads	27
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis	27
The Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular Complications	27
Correlation Analysis of Hemoglobin-to-Red Blood Cell Distribution Width Ratio and Frailty in Elderly Patients With Coronary Heart Disease	26
Identification of Potential Biomarkers and Immune Infiltration Characteristics in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Analysis	26
Association Between Triglyceride Glucose Index and Risk of New-Onset Diabetes Among Chinese Adults: Findings From the China Health and Retirement Longitudinal Study	26
Update on Transcatheter Tricuspid Valve Replacement Therapies	26
Smoking and the Pathophysiology of Peripheral Artery Disease	26
Increased Catecholamine Levels and Inflammatory Mediators Alter Barrier Properties of Brain Microvascular Endothelial Cells in vitro	26
Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances	26
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region	26
New Developments in Exosomal lncRNAs in Cardiovascular Diseases	26
Role of Exosomal miRNAs in Heart Failure	26
Biventricular Longitudinal Strain Predict Mortality in COVID-19 Patients	26
Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease	26
Partitioning the Right Ventricle Into 15 Segments and Decomposing Its Motion Using 3D Echocardiography-Based Models: The Updated ReVISION Method	26
Causal associations between gut microbiome and cardiovascular disease: A Mendelian randomization study	26
Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm	26
Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality	26
Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction—A Specific HFpEF Phenotype	26
Long-Term Clinical Outcomes in Patients With an Acute ST-Segment-Elevation Myocardial Infarction Stratified by Angiography-Derived Index of Microcirculatory Resistance	26
Cinematic Rendering in Mixed-Reality Holograms: A New 3D Preoperative Planning Tool in Pediatric Heart Surgery	26
Shared Genetic Liability and Causal Associations Between Major Depressive Disorder and Cardiovascular Diseases	26
COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications	26
Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation	26
Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger	25
The Role of microRNAs in Heart Failure: A Systematic Review	25
Roles of Ferroptosis in Cardiovascular Diseases	25
Radiation-Induced Vascular Disease—A State-of-the-Art Review	25
Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites	25
Intravascular Ultrasound in the Endovascular Treatment of Patients With Peripheral Arterial Disease: Current Role and Future Perspectives	25
Trends in Prevalence of Hypertension and Hypertension Phenotypes Among Chinese Children and Adolescents Over Two Decades (1991–2015)	25
The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System	25
Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target	25
Cardiac Involvement in Recovered Patients From COVID-19: A Preliminary 6-Month Follow-Up Study	25
Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment	25
Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients	25
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination	25
Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention	25
The Neutrophil-to-Lymphocyte Ratio Is an Important Indicator Predicting In-Hospital Death in AMI Patients	25
The Emerging Role of Neutrophil Extracellular Traps in Arterial, Venous and Cancer-Associated Thrombosis	25
Predictive Value of Gensini Score in the Long-Term Outcomes of Patients With Coronary Artery Disease Who Underwent PCI	25
Mini Review: Deep Learning for Atrial Segmentation From Late Gadolinium-Enhanced MRIs	24
Transcatheter Tricuspid Valve Intervention: Coaptation Devices	24
Where the Action Is—Leukocyte Recruitment in Atherosclerosis	24
Prognostic Outcomes in Acute Myocardial Infarction Patients Without Standard Modifiable Risk Factors: A Multiethnic Study of 8,680 Asian Patients	24
Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease	24
Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment	24
Oral, Tongue-Coating Microbiota, and Metabolic Disorders: A Novel Area of Interactive Research	24
Single Cell Transcriptomic Analysis Reveals Organ Specific Pericyte Markers and Identities	24
Gut Microbiota in Heart Failure Patients With Preserved Ejection Fraction (GUMPTION Study)	24
Obesity and Cardiovascular Disease: The Emerging Role of Inflammation	24
Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis	24
Right Ventricular Damage in COVID-19: Association Between Myocardial Injury and COVID-19	24
Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward	24
Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review	24
Feasibility and Outcomes of Upgrading to Left Bundle Branch Pacing in Patients With Pacing-Induced Cardiomyopathy and Infranodal Atrioventricular Block	24
MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target	24
Territory-Wide Chinese Cohort of Long QT Syndrome: Random Survival Forest and Cox Analyses	24
Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis	24
Atrial Fibrillation and Depression: A Bibliometric Analysis From 2001 to 2021	23
Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions	23
Mitochondrial Metabolism in Myocardial Remodeling and Mechanical Unloading: Implications for Ischemic Heart Disease	23
IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial	23
The Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance	23
Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis	23
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways	23
Electronic Cigarette Use and the Risk of Cardiovascular Diseases	23
Therapeutic Applications of Extracellular Vesicles for Myocardial Repair	23
Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke	23
Burden of Peripheral Artery Disease and Its Attributable Risk Factors in 204 Countries and Territories From 1990 to 2019	23
Left Ventricular Myocardial Septal Pacing in Close Proximity to LBB Does Not Prolong the Duration of the Left Ventricular Lateral Wall Depolarization Compared to LBB Pacing	23
Recent Progress in in vitro Models for Atherosclerosis Studies	23
Regulation of Endothelial and Vascular Functions by Carbon Monoxide via Crosstalk With Nitric Oxide	23
Mechanisms of Action of MiRNAs and LncRNAs in Extracellular Vesicle in Atherosclerosis	23
Recent Advances in Biomechanical Characterization of Thoracic Aortic Aneurysms	23
Atrial Cardiomyopathy: An Emerging Cause of the Embolic Stroke of Undetermined Source	23
Prognostic Value of Right Ventricular Ejection Fraction Assessed by 3D Echocardiography in COVID-19 Patients	23
The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders	23
NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease	22
Cognitive Impairment in Heart Failure: Landscape, Challenges, and Future Directions	22
Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy	22
Microvascular Angiopathic Consequences of COVID-19	22
Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects	22
Abnormalities of Skeletal Muscle, Adipocyte Tissue, and Lipid Metabolism in Heart Failure: Practical Therapeutic Targets	22
COVID-19 and Cardiomyopathy: A Systematic Review	22
Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance	22
Empagliflozin Decreases Lactate Generation in an NHE-1 Dependent Fashion and Increases α-Ketoglutarate Synthesis From Palmitate in Type II Diabetic Mouse Hearts	22
The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway	22
Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease	22
Environmental Risk Factors and Congenital Heart Disease: An Umbrella Review of 165 Systematic Reviews and Meta-Analyses With More Than 120 Million Participants	22